Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Benjamin Maynor
Robert Frank Roscigno
Jacob J. Sprague
Brian T. Farrer
Date of Patent
September 5, 2023
Patent Application Number
17390514
Date Filed
July 30, 2021
Patent Citations
...
Patent Primary Examiner
A dry powder inhalation treatment for pulmonary arterial hypertension includes a dose of dry particles comprising greater than 25 micrograms of treprostinil enclosed in a capsule. The dry particles can include treprostinil, a wetting agent, a hydrophobicity modifying agent, a pH modifying agent and a buffer. A method of treating a patient having pulmonary arterial hypertension includes providing a patient a dry powder inhaler, providing the patient at least one capsule for use in the dry powder inhaler, the capsule including at least 25 micrograms of treprostinil.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
